Standard

Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation. / Shevchenko, Julia A.; Nazarov, Kirill V.; Gizbrekht, Alina A. et al.

In: Cells, Vol. 15, No. 16, 1430, 08.08.2026.

Research output: Contribution to journal › Article › peer-review

Harvard

APA

Vancouver

Shevchenko JA, Nazarov KV, Gizbrekht AA, Savostyanova TA, Zakhareva AP, Sennikov SV. Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation. Cells. 2026 Aug 8;15(16):1430. doi: 10.3390/cells15161430

Author

BibTeX

@article{6982ec10aa1546baa1cd86a236bd8eaf,
title = "Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation",
abstract = "Nucleated erythroid cells (NECs) are emerging as important immunoregulators at the feto–maternal interface, yet their chemokine profiles and functional dynamics across pregnancy remain poorly understood. Using a murine allogeneic pregnancy model (CBA × C57Bl/6), we isolated placental and splenic TER-119+ NECs at mid- (E12.5) and late (E19.5) gestation. Chemokine production (13-plex), chemokine receptor expression (qPCR), immunosuppressive molecules (PD-L1, TGF-β, and ROS), T-cell proliferation (CFSE), and immune cell migration (Transwell) were assessed. CD45+ placental NECs were the main producers of PD-L1, TGF-β, and ROS, with maximal expression at E19.5, suggesting their potential contribution to the immunosuppressive functions observed in the total TER-119+ population. Chemokine production showed a striking shift in CCL17 and CXCL9 from the spleen to the placenta as pregnancy advanced (E12.5 → E19.5). Splenic NECs displayed dominant expressions of CCR3 and CXCR4. Unexpectedly, CCL2 and CCL4 blockade enhanced immune cell migration toward placental NECs at E19.5. Placental nucleated erythroid cells potently suppressed T-cell proliferation at E12.5, and this suppressive capacity remained stable until full term. Placental NECs undergo dynamic chemokine reprogramming while maintaining stable T-cell suppression. The paradoxical enhancement of migration after CCL2/CCL4 blockade suggests a complex chemokine network warranting further investigation. These findings provide new insights into the immunobiology of pregnancy and may have implications for understanding pregnancy complications.",
keywords = "CCL17, CCR3, CXCL9, CXCR4, PD-L1, ROS, TGF-β, chemokines, immunosuppression, nucleated erythroid cells, placenta, pregnancy, беременность, плацента, ядросодержащие эритроидные клетк, хемокины, CCL17, CXCL9, иммуносупрессия, PD-L1, TGF-β, АФК, CCR3, CXCR4",
author = "Shevchenko, {Julia A.} and Nazarov, {Kirill V.} and Gizbrekht, {Alina A.} and Savostyanova, {Tatyana A.} and Zakhareva, {Alena P.} and Sennikov, {Sergey V.}",
note = "Shevchenko, J.A.; Nazarov, K.V.; Gizbrekht, A.A.; Savostyanova, T.A.; Zakhareva, A.P.; Sennikov, S.V. Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation. Cells 2026, 15, 1430. https://doi.org/10.3390/cells15161430 This work was carried out with the support of the Russian Science Foundation, project number 25-25-00121 (Available online: https://rscf.ru/project/25-25-00121 (accessed on 5 August 2026)). ",
year = "2026",
month = aug,
day = "8",
doi = "10.3390/cells15161430",
language = "English",
volume = "15",
journal = "Cells",
issn = "2073-4409",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "16",

}

RIS

TY - JOUR

T1 - Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation

AU - Shevchenko, Julia A.

AU - Nazarov, Kirill V.

AU - Gizbrekht, Alina A.

AU - Savostyanova, Tatyana A.

AU - Zakhareva, Alena P.

AU - Sennikov, Sergey V.

N1 - Shevchenko, J.A.; Nazarov, K.V.; Gizbrekht, A.A.; Savostyanova, T.A.; Zakhareva, A.P.; Sennikov, S.V. Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation. Cells 2026, 15, 1430. https://doi.org/10.3390/cells15161430 This work was carried out with the support of the Russian Science Foundation, project number 25-25-00121 (Available online: https://rscf.ru/project/25-25-00121 (accessed on 5 August 2026)).

PY - 2026/8/8

Y1 - 2026/8/8

N2 - Nucleated erythroid cells (NECs) are emerging as important immunoregulators at the feto–maternal interface, yet their chemokine profiles and functional dynamics across pregnancy remain poorly understood. Using a murine allogeneic pregnancy model (CBA × C57Bl/6), we isolated placental and splenic TER-119+ NECs at mid- (E12.5) and late (E19.5) gestation. Chemokine production (13-plex), chemokine receptor expression (qPCR), immunosuppressive molecules (PD-L1, TGF-β, and ROS), T-cell proliferation (CFSE), and immune cell migration (Transwell) were assessed. CD45+ placental NECs were the main producers of PD-L1, TGF-β, and ROS, with maximal expression at E19.5, suggesting their potential contribution to the immunosuppressive functions observed in the total TER-119+ population. Chemokine production showed a striking shift in CCL17 and CXCL9 from the spleen to the placenta as pregnancy advanced (E12.5 → E19.5). Splenic NECs displayed dominant expressions of CCR3 and CXCR4. Unexpectedly, CCL2 and CCL4 blockade enhanced immune cell migration toward placental NECs at E19.5. Placental nucleated erythroid cells potently suppressed T-cell proliferation at E12.5, and this suppressive capacity remained stable until full term. Placental NECs undergo dynamic chemokine reprogramming while maintaining stable T-cell suppression. The paradoxical enhancement of migration after CCL2/CCL4 blockade suggests a complex chemokine network warranting further investigation. These findings provide new insights into the immunobiology of pregnancy and may have implications for understanding pregnancy complications.

AB - Nucleated erythroid cells (NECs) are emerging as important immunoregulators at the feto–maternal interface, yet their chemokine profiles and functional dynamics across pregnancy remain poorly understood. Using a murine allogeneic pregnancy model (CBA × C57Bl/6), we isolated placental and splenic TER-119+ NECs at mid- (E12.5) and late (E19.5) gestation. Chemokine production (13-plex), chemokine receptor expression (qPCR), immunosuppressive molecules (PD-L1, TGF-β, and ROS), T-cell proliferation (CFSE), and immune cell migration (Transwell) were assessed. CD45+ placental NECs were the main producers of PD-L1, TGF-β, and ROS, with maximal expression at E19.5, suggesting their potential contribution to the immunosuppressive functions observed in the total TER-119+ population. Chemokine production showed a striking shift in CCL17 and CXCL9 from the spleen to the placenta as pregnancy advanced (E12.5 → E19.5). Splenic NECs displayed dominant expressions of CCR3 and CXCR4. Unexpectedly, CCL2 and CCL4 blockade enhanced immune cell migration toward placental NECs at E19.5. Placental nucleated erythroid cells potently suppressed T-cell proliferation at E12.5, and this suppressive capacity remained stable until full term. Placental NECs undergo dynamic chemokine reprogramming while maintaining stable T-cell suppression. The paradoxical enhancement of migration after CCL2/CCL4 blockade suggests a complex chemokine network warranting further investigation. These findings provide new insights into the immunobiology of pregnancy and may have implications for understanding pregnancy complications.

KW - CCL17

KW - CCR3

KW - CXCL9

KW - CXCR4

KW - PD-L1

KW - ROS

KW - TGF-β

KW - chemokines

KW - immunosuppression

KW - nucleated erythroid cells

KW - placenta

KW - pregnancy

KW - беременность

KW - плацента

KW - ядросодержащие эритроидные клетк

KW - хемокины

KW - CCL17

KW - CXCL9

KW - иммуносупрессия

KW - PD-L1

KW - TGF-β

KW - АФК

KW - CCR3

KW - CXCR4

UR - https://www.mendeley.com/catalogue/d006aacf-c7fa-3abd-8eaf-667eb17edbda/

UR - https://www.scopus.com/pages/publications/105048298059

U2 - 10.3390/cells15161430

DO - 10.3390/cells15161430

M3 - Article

C2 - 42645158

VL - 15

JO - Cells

JF - Cells

SN - 2073-4409

IS - 16

M1 - 1430

ER -

ID: 85320269